论文部分内容阅读
摘要目的探讨定向射频消融(RFA)治疗转移性后椎体肿瘤的可行性和安全性。材料与方法该回顾性研究经伦理审查委员会批准并符合HIPAA,免除签署病人知情同意。
Abstract Objective To investigate the feasibility and safety of directional radiofrequency ablation (RFA) in the treatment of metastatic vertebral body tumors. Materials and Methods This retrospective study was approved by the Ethics Review Board and complies with HIPAA to avoid the signing of patient informed consent.